AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

  • Mark F. Lew
  • , Robert A. Hauser
  • , Stuart H. Isaacson
  • , Daniel Truong
  • , Atul T. Patel
  • , Allison Brashear
  • , William Ondo
  • , Pascal Maisonobe
  • , Khashayar Dashtipour
  • , Laxman Bahroo
  • , Stefan Wietek

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number100115
JournalClinical Parkinsonism and Related Disorders
Volume5
DOIs
StatePublished - Jan 2021

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Keywords

  • AbobotulinumtoxinA
  • Cervical dystonia
  • Dilution
  • Dosing flexibility
  • Treatment

Cite this